ParcelBio, a biotechnology company developing a new class of potent and durable mRNA medicines, today announced it has raised $13 million in seed financing led by Breyer Capital, with participation ...
Financing led by Breyer Capital with participation from General Catalyst, Y Combinator, Metaplanet, SurgePoint Capital, ZAKA VC, and other investors Proceeds will advance APEXm™ platform and in vivo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results